JNJ-26854165

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-26854165, covering 2010-03-26 to 2010-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors. [Phase 1]

See pricing